{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T09:13:03Z","timestamp":1787735583633,"version":"build-2784847793"},"reference-count":70,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background: Unfractionated heparin (UFH) is the standard anticoagulant during cardiopulmonary bypass (CPB). A clinically relevant subset develops heparin resistance (HR)\u2014failure to reach adequate anticoagulation with usual UFH\u2014raising thrombotic risk and complicating perioperative care. Objectives: To synthesize contemporary evidence on the mechanisms, clinical implications, and perioperative management of HR in adult cardiac surgery with CPB. Methods: This narrative review synthesizes contemporary evidence on the epidemiology, mechanisms, recognition, and management of HR in adult cardiac surgery with CPB, emphasizing clinically actionable points. Results: Incidence varies across centers and definitions. Mechanisms include antithrombin (AT) deficiency or consumption and AT-independent drivers such as systemic inflammation or sepsis, protein-loss states, thrombocytosis, hyperfibrinogenemia, obesity, prior heparin exposure, and drug interactions. Sole reliance on activated clotting time (ACT) may misestimate anticoagulant effect; anti\u2013factor Xa (anti-Xa) assays or heparin titration systems improve assessment when available. Management is stepwise: UFH dose escalation; targeted AT supplementation (or fresh frozen plasma where concentrates are unavailable); and transition to direct thrombin inhibitors when HR persists or UFH is contraindicated. Protocolized pathways and multidisciplinary coordination reduce delays and adverse events. Conclusions: HR is a multifactorial, common challenge in CPB. Pre-bypass risk assessment, multimodal monitoring, and an algorithm prioritizing UFH optimization, AT repletion, and timely use of direct thrombin inhibitors provide a pragmatic framework to limit thrombosis and bleeding. Harmonized definitions and comparative trials remain priorities.<\/jats:p>","DOI":"10.3390\/medicina61122088","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:24:17Z","timestamp":1763979857000},"page":"2088","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Heparin Resistance in Cardiac Surgery with Cardiopulmonary Bypass: Mechanisms, Clinical Implications, and Evidence-Based Management"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3161-8578","authenticated-orcid":false,"given":"Karina E.","family":"Rivera Jim\u00e9nez","sequence":"first","affiliation":[{"name":"Instituto Nacional Cardiovascular, Lima 15072, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahaira M.","family":"Mamani Ticona","sequence":"additional","affiliation":[{"name":"Sociedad Cient\u00edfica de Estudiantes de Medicina de la Universidad Nacional del Altiplano (SOCIEM UNA), Puno 21001, Peru"},{"name":"Facultad de Medicina Humana, Universidad Nacional del Altiplano, Puno 21001, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Gutierrez-Chavez","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Continental, Cusco 08000, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian O.","family":"Astudillo","sequence":"additional","affiliation":[{"name":"Hospital San Sebasti\u00e1n, Cuenca 010111, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6863-1293","authenticated-orcid":false,"given":"Edisson","family":"Calle","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias Quimicas y de la Salud, Universidad Tecnica de Machala, Machala 070205, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo A. Torres","family":"Heredia","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud, Universidad Privada Antenor Orrego, Trujillo 13008, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9826-6314","authenticated-orcid":false,"given":"Dario S.","family":"Lopez Delgado","sequence":"additional","affiliation":[{"name":"Hospital Universitario Departamental de Nari\u00f1o, Pasto 520001, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6546-3570","authenticated-orcid":false,"given":"Oriana","family":"Rivera-Lozada","sequence":"additional","affiliation":[{"name":"Vicerrectorado de Investigacion, Universidad Se\u00f1or de Sipan, Chiclayo 14002, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshuan J.","family":"Barboza","sequence":"additional","affiliation":[{"name":"Vicerrectorado de Investigacion, Universidad Se\u00f1or de Sipan, Chiclayo 14002, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1055\/s-0044-1786990","article-title":"Pleiotropic effects of heparin and its monitoring in the clinical practice","volume":"50","author":"Arachchillage","year":"2024","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-0039-3400273","article-title":"Hemostatic management of extracorporeal circuits including cardiopulmonary bypass and extracorporeal membrane oxygenation","volume":"46","author":"Fang","year":"2020","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1213\/ANE.0000000000003981","article-title":"Anticoagulation management and heparin resistance during cardiopulmonary bypass: A survey of Society of Cardiovascular Anesthesiologists members","volume":"129","author":"Sniecinski","year":"2019","journal-title":"Anesth. Analg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11748-023-01936-5","article-title":"Investigation of real-world heparin resistance and anticoagulation management prior to cardiopulmonary bypass: Report from a nationwide survey by the Japanese Association for Thoracic Surgery Heparin Resistance Working Group","volume":"72","author":"Ito","year":"2024","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1053\/j.jvca.2022.06.021","article-title":"Heparin resistance during cardiopulmonary bypass in adult cardiac surgery","volume":"36","author":"Chen","year":"2022","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10047-024-01435-1","article-title":"Contributing factors to heparin resistance during cardiopulmonary bypass","volume":"27","author":"Yamashiro","year":"2024","journal-title":"J. Artif. Organs"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jtha.2024.01.001","article-title":"Finding a common definition of heparin resistance in adult cardiac surgery: Communication from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis","volume":"22","author":"Levy","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1051\/ject\/2024015","article-title":"Heparin resistance management during cardiac surgery: A literature review and future directions","volume":"56","author":"Butt","year":"2024","journal-title":"J. Extra Corpor. Technol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.athoracsur.2017.09.061","article-title":"The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of Extracorporeal Technology: Clinical practice guidelines\u2014Anticoagulation during cardiopulmonary bypass","volume":"105","author":"Baker","year":"2018","journal-title":"Ann. Thorac. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1053\/j.jvca.2025.04.004","article-title":"Analysis of risk factors for heparin resistance during cardiac surgery: Does antithrombin deficiency cause heparin resistance?","volume":"39","author":"Kim","year":"2025","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4310407","DOI":"10.1155\/2019\/4310407","article-title":"Preoperative low-molecular-weight heparin prophylaxis is associated with increased heparin resistance frequency in on-pump coronary artery bypass graft surgery","volume":"2019","author":"Saydam","year":"2019","journal-title":"Cardiol. Res. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.21608\/asmj.2024.311922.1296","article-title":"Incidence of heparin resistance during cardiopulmonary bypass in adult cardiac surgery in the era of COVID-19","volume":"75","author":"Elsayegh","year":"2024","journal-title":"Ain Shams Med. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1053\/j.jvca.2021.05.024","article-title":"Infective endocarditis is a risk factor for heparin resistance in adult cardiovascular surgical procedures: A retrospective study","volume":"35","author":"Kimura","year":"2021","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/j.jtha.2023.08.013","article-title":"Defining heparin resistance: Communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis","volume":"21","author":"Levy","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/20009666.2018.1466599","article-title":"To be or not to be a case of heparin resistance","volume":"8","author":"Durrani","year":"2018","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0267659115583525","article-title":"Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery","volume":"31","author":"McNair","year":"2016","journal-title":"Perfusion"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.21470\/1678-9741-2019-0387","article-title":"Heparin-coated vs. non-coated cardiopulmonary bypass circuits: Comparing immediate results with different target activated clotting times","volume":"35","author":"Hanedan","year":"2020","journal-title":"Braz. J. Cardiovasc. Surg."},{"key":"ref_18","first-page":"ivaf002","article-title":"2024 EACTS\/EACTAIC\/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery","volume":"40","author":"Wahba","year":"2025","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bjae.2022.12.003","article-title":"Anticoagulation for cardiopulmonary bypass: Part one","volume":"23","author":"Cartwright","year":"2023","journal-title":"BJA Educ."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1053\/j.jvca.2025.05.057","article-title":"Heparin resistance: Definition, risk factors, and therapeutic approaches","volume":"39","author":"Bolliger","year":"2025","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s10047-024-01462-y","article-title":"Relation between antithrombin-III activity and activated clotting time for cardiopulmonary bypass","volume":"28","author":"Yamashiro","year":"2025","journal-title":"J. Artif. Organs."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjh.15869","article-title":"Advances in understanding the molecular mechanisms that maintain normal haemostasis","volume":"186","author":"Preston","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10760296231205279","DOI":"10.1177\/10760296231205279","article-title":"Antithrombin therapy: Current state and future outlook","volume":"29","author":"Rodgers","year":"2023","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1111\/jth.15052","article-title":"Anticoagulant and signaling functions of antithrombin","volume":"18","author":"Rezaie","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2018.07.008","article-title":"The genetics of antithrombin","volume":"169","author":"Corral","year":"2018","journal-title":"Thromb. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1111\/ijlh.13886","article-title":"Mixing study to diagnose heparin resistance caused by functional antithrombin deficiency","volume":"44","author":"Bahabri","year":"2022","journal-title":"Int. J. Lab. Hematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1213\/ANE.0b013e3181ce1ffa","article-title":"Heparin dose response is independent of preoperative antithrombin activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations","volume":"111","author":"Garvin","year":"2010","journal-title":"Anesth. Analg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3324\/haematol.2018.210666","article-title":"Incidence and features of thrombosis in children with inherited antithrombin deficiency","volume":"104","author":"Orlando","year":"2019","journal-title":"Haematologica"},{"key":"ref_29","first-page":"e18265","article-title":"A case of COVID-19-related coagulopathy complications and heparin resistance","volume":"13","author":"Chowdhry","year":"2021","journal-title":"Cureus"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/00185787221111743","article-title":"Heparin resistance in SARS-CoV-2 infected patients with venous thromboembolism","volume":"57","author":"Chau","year":"2022","journal-title":"Hosp. Pharm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1089253220966515","article-title":"Surgical revascularization with cardiopulmonary bypass on a patient with severe COVID-19","volume":"25","author":"Montandrau","year":"2021","journal-title":"Semin. Cardiothorac. Vasc. Anesth."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMra2104091","article-title":"Heparin resistance: Clinical perspectives and management strategies","volume":"385","author":"Levy","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40981-016-0063-4","article-title":"Emergency cardiac surgery and heparin resistance in a patient with essential thrombocythemia","volume":"2","author":"Nakanishi","year":"2016","journal-title":"JA Clin. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/aor.14171","article-title":"Narrative review of the systemic inflammatory reaction to cardiac surgery and cardiopulmonary bypass","volume":"46","author":"Squiccimarro","year":"2022","journal-title":"Artif. Organs"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.athoracsur.2018.01.068","article-title":"Predictors of heparin resistance before cardiovascular operations in adults","volume":"105","author":"Kawatsu","year":"2018","journal-title":"Ann. Thorac. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40981-023-00642-8","article-title":"Relationship between estimated and observed heparin sensitivity indices in cardiac and thoracic aortic surgery","volume":"9","author":"Nakatani","year":"2023","journal-title":"JA Clin. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.soard.2019.03.048","article-title":"Prospective assessment of fibrinolysis in morbid obesity: Tissue plasminogen activator resistance improves after bariatric surgery","volume":"15","author":"Samuels","year":"2019","journal-title":"Surg. Obes. Relat. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/08971900211004837","article-title":"Recurrent thrombi in an obese patient with history of bariatric surgery despite anti-Xa therapy","volume":"35","author":"Briggler","year":"2022","journal-title":"J. Pharm. Pract."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/EJA.0000000000000784","article-title":"Adjusted calculation model of heparin management during cardiopulmonary bypass in obese patients: A randomised controlled trial","volume":"35","author":"Vienne","year":"2018","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jvn.2022.02.003","article-title":"Review of case study: Chowdhry, Moshman, and Carroll (2021). A case of COVID-19-related coagulopathy complications and heparin resistance","volume":"40","author":"Brown","year":"2022","journal-title":"J. Vasc. Nurs."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.53350\/pjmhs22166126","article-title":"Incidence of heparin resistance after preoperative heparin therapy in patients undergoing open heart surgery","volume":"16","author":"Ali","year":"2022","journal-title":"Pak. J. Med. Health Sci."},{"key":"ref_42","first-page":"707","article-title":"Mechanism and clinical treatment strategy of heparin resistance","volume":"103","author":"Men","year":"2023","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1053\/j.jvca.2023.12.001","article-title":"Cardiopulmonary bypass circuit obstruction and urgent replacement after the administration of andexanet alfa","volume":"38","author":"Nozumi","year":"2023","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_44","first-page":"e50856","article-title":"A case of andexanet alfa-induced heparin resistance in emergent aortic surgery: Successful anticoagulation management using antithrombin administration","volume":"15","author":"Takagi","year":"2023","journal-title":"Cureus"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1053\/j.jvca.2022.07.018","article-title":"Andexanet alfa-induced heparin resistance missing from SCA blood management in cardiac surgery guidelines","volume":"36","author":"Pauls","year":"2022","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1177\/02676591221109143","article-title":"Paraprotein-associated heparin resistance during cardiopulmonary bypass","volume":"38","author":"Khuong","year":"2023","journal-title":"Perfusion"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/02676591211073783","article-title":"Goal-directed perfusion for reducing acute kidney injury in cardiac surgery: A systematic review and meta-analysis","volume":"38","author":"Gao","year":"2023","journal-title":"Perfusion"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1177\/02676591231197990","article-title":"Efficacy of the Hepcon system in reducing hemorrhagic and thrombotic complications in antiphospholipid syndrome patients undergoing cardiac surgery","volume":"39","author":"Michael","year":"2024","journal-title":"Perfusion"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/labmed\/lmz014","article-title":"Intraoperative monitoring of heparin: Comparison of activated coagulation time and whole blood heparin measurements by different point-of-care devices with heparin concentration by laboratory-performed plasma anti-Xa assay","volume":"50","author":"Thompson","year":"2019","journal-title":"Lab. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/hematology.2024000659","article-title":"Troubleshooting heparin resistance","volume":"2024","author":"Maier","year":"2024","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Ma, M., Liang, S., Zhu, J., Liang, S., Zhu, J., Dai, M., Jia, Z., Huang, H., and He, Y. (2022). The efficacy and safety of bivalirudin versus heparin in the anticoagulation therapy of extracorporeal membrane oxygenation: A systematic review and meta-analysis. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.771563"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MAT.0000000000001196","article-title":"Thromboelastometry, thromboelastography, and conventional tests to assess anticoagulation during extracorporeal support: A prospective observational study","volume":"67","author":"Giani","year":"2021","journal-title":"ASAIO J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"680","DOI":"10.23736\/S0375-9393.22.16119-5","article-title":"Comparison of coagulation monitoring using ROTEM and Sonoclot devices in cardiac surgery: A single-center prospective observational study","volume":"88","author":"Vandenheuvel","year":"2022","journal-title":"Minerva Anestesiol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Tshikudi, D.M., Wirth, A.G., Andrawes, M.N., and Nadkarni, S.K. (2019, January 23\u201325). Anticoagulation and hemostasis monitoring during cardiac surgery with a drop of whole blood using a novel optical sensor. Proceedings of the European Conference on Biomedical Optics, Munich, Germany.","DOI":"10.1117\/12.2537923"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e19497","DOI":"10.1016\/j.heliyon.2023.e19497","article-title":"Antithrombin concentrates may benefit cardiopulmonary bypass patients with suspected heparin resistance: A retrospective analysis of real-world data","volume":"9","author":"Bader","year":"2023","journal-title":"Heliyon"},{"key":"ref_56","first-page":"100072","article-title":"Bivalirudin resistance during heart transplantation surgery","volume":"6","author":"Urbanowicz","year":"2021","journal-title":"Transplant. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/02676591231221708","article-title":"Bivalirudin anticoagulation for cardiopulmonary bypass during cardiac surgery","volume":"40","author":"Meshulami","year":"2025","journal-title":"Perfusion"},{"key":"ref_58","first-page":"9945225","article-title":"Anticoagulation with argatroban in a patient with heparin-induced thrombocytopenia and renal insufficiency undergoing orthotopic heart transplantation","volume":"2021","author":"Green","year":"2021","journal-title":"Case Rep. Anesthesiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1510\/icvts.2009.215848","article-title":"Argatroban as a substitute of heparin during cardiopulmonary bypass: A safe alternative?","volume":"10","author":"Follis","year":"2010","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"ref_60","first-page":"e1035","article-title":"The addition of tirofiban infusion to heparin for intraoperative heparin resistance associated with Marfan syndrome","volume":"50","year":"2022","journal-title":"Colomb. J. Anesthesiol."},{"key":"ref_61","unstructured":"Ratner, B.D., Hoffman, A.S., Schoen, F.J., and Lemons, J.E. (2013). Chapter II.5.5\u2014Extracorporeal Artificial Organs. Biomaterials Science, Academic Press. [3rd ed.]."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0037-1609019","article-title":"Is 300 seconds ACT safe and efficient during MiECC procedures?","volume":"67","author":"Bauer","year":"2019","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1051\/ject\/2025001","article-title":"Comparative analysis of perioperative outcomes between hybrid system and MiECC: A prospective pilot study","volume":"57","year":"2025","journal-title":"J. Extra Corpor. Technol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1177\/02676591231215282","article-title":"Heparin consumption and inflammatory response according to the coating of cardiopulmonary bypass circuits in cardiac surgery: A retrospective analysis","volume":"39","author":"Mathieu","year":"2024","journal-title":"Perfusion"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.jvca.2023.11.015","article-title":"Use of a new standardized unfractionated heparin protocol for left-sided ablation procedures improves time in the therapeutic ACT range","volume":"38","author":"Ural","year":"2024","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"100089","DOI":"10.1016\/j.rpth.2023.100089","article-title":"Cardiac surgery in acute heparin-induced thrombocytopenia managed with therapeutic plasma exchange and intravenous immunoglobulin","volume":"7","author":"Grazioli","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Chabata, C.V., Yu, H., Ke, L., Frederiksen, J.W., Patel, P.A., Sullenger, B.A., and Thalji, N.K. (2024). Andexanet alfa-associated heparin resistance in cardiac surgery: Mechanism and in vitro perspectives. bioRxiv.","DOI":"10.1101\/2024.09.09.612152"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/1874434602115010074","article-title":"The effectiveness of care bundles including the braden scale for preventing hospital acquired pressure ulcers in older adults hospitalized in ICUs: A systematic review","volume":"15","author":"Floyd","year":"2021","journal-title":"Open Nurs. J."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Lozada-Urbano, M., Huam\u00e1n, F., Xirinachs, Y., Rivera-Lozada, O., Alvarez-Risco, A., and Y\u00e1\u00f1ez, J.A. (2022). Poverty, Household Structure and Consumption of Foods Away from Home in Peru in 2019: A Cross-Sectional Study. Foods, 11.","DOI":"10.3390\/foods11172547"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"8825450","DOI":"10.1155\/2021\/8825450","article-title":"The Effect of WeChat-Based Online Instruction on EFL Learners\u2019 Vocabulary Knowledge","volume":"2021","author":"Namaziandost","year":"2021","journal-title":"Educ. Res. Int."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/12\/2088\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T05:16:51Z","timestamp":1764047811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/12\/2088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":70,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["medicina61122088"],"URL":"https:\/\/doi.org\/10.3390\/medicina61122088","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]}}}